Featured Research

from universities, journals, and other organizations

Consumers judge their risk of catching an illness by the cost of the cure

Date:
January 4, 2013
Source:
Tulane University
Summary:
Consumers make irrational inferences about their health risks based on the price of their medicine.

When it comes to calculating their odds of getting the flu, consumers look to an unlikely gauge -- the price of the flu shot -- to measure their risk, according to a new study co-authored by a Tulane University researcher.

The study found that consumers make judgments about their risk of catching an illness based on the cost of its medication. The higher the price, the less they think they're at risk, says co-author Janet Schwartz, assistant professor of marketing at Tulane's A.B. Freeman School of Business.

"Your chance of winning at blackjack has nothing to do with how big the payout is and most people know that," Schwartz says. "But when it comes to understanding what prices reflect for medicine, people look at the price and they do think that it somehow tells them something about their own risk of getting a disease. In reality, those two factors are completely independent."

Researchers conducted several surveys to gauge consumers' reactions to different medications based on cost and perceived risk. For example, they presented different health messages about getting a flu shot, emphasizing individual risk in one scenario and the larger public health risks in another. They told some that the vaccine cost $25 and others $125. Even though all were told the cost would be covered by insurance, those in the high-price group felt that they were at a lower risk of getting the flu.

Researchers found that consumers instinctively believed that important medication like flu vaccine should be affordably priced to be widely accessible. When priced high and perceivably out of reach for some, consumers inferred that the medicine must not be all that necessary and the risk of getting the illness must be lower. The results of the study, which is co-authored by Adriana Samper of the W.P. Carey School of Business at Arizona State University, will be published in the April issue of the Journal of Consumer Research.


Story Source:

The above story is based on materials provided by Tulane University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Adriana Samper, Janet A. Schwartz. Price Inferences for Sacred versus Secular Goods: Changing the Price of Medicine Influences Perceived Health Risk. Journal of Consumer Research, 2012; 000 DOI: 10.1086/668639

Cite This Page:

Tulane University. "Consumers judge their risk of catching an illness by the cost of the cure." ScienceDaily. ScienceDaily, 4 January 2013. <www.sciencedaily.com/releases/2013/01/130104143451.htm>.
Tulane University. (2013, January 4). Consumers judge their risk of catching an illness by the cost of the cure. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2013/01/130104143451.htm
Tulane University. "Consumers judge their risk of catching an illness by the cost of the cure." ScienceDaily. www.sciencedaily.com/releases/2013/01/130104143451.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins